First Page | Document Content | |
---|---|---|
![]() Date: 2014-12-12 12:42:08Clinical Data Management Pharmacology Drug discovery Pharmaceutical industry Critical Path Institute Patient-reported outcome Clinical trial Electronic patient-reported outcome Mpro Research Clinical research Pharmaceutical sciences | Add to Reading List |
![]() | The Critical Path to TB Drug Regimens Initiative Jan Gheuens, MD, PhD Global Health, Bill & Melinda Gates Foundation Addis Ababa, August 18th, 2010DocID: 1aMKd - View Document |
![]() | PARTNERSHIPS T he Global Alliance for TB Drug Development (TB Alliance) is a product development partnership (PDP), working toDocID: 1avZ3 - View Document |
![]() | Critical Path Opportunities Report March 2006 Critical Path Opportunities Report and ListDocID: 12w9D - View Document |
![]() | Translational Safety in Drug Development – Innovations and Challenges A Joint Regional Chapter Meeting with SCCSOT and the Critical Path Institute Accelerating the Path to a Healthier WorldDocID: ZUkW - View Document |
![]() | FDA Co-Sponsorship AgreementsDocID: Zf5j - View Document |